KRAS and adenocarcinoma: In adenocarcinoma, GTP-bound activated K-Ras4B is specifically regulated by CaM [19,20,24], and such a finding is supported by the clinical observation that higher calcium concentration in serum can lead to the poor prognosis of the K-Ras4B-driven PDAC [23].